Asceneuron SA Company Profile, Contacts & Intelligence

Asceneuron SA Overview

Asceneuron is a clinical stage biotech company focused on the development of orally bioavailable therapeutics for debilitating neurodegenerative disorders with high unmet medical need. The pipeline reflects our ambition to develop treatments for a wide a range of neurodegenerative diseases including orphan tauopathies, Alzheimer’s and Parkinson’s disease. Asceneuron has two clinical stage small molecule O-GlcNAcase inhibitors in development for the treatment of proteinopathies including Parkinson’s Disease, Alzheimer’s disease and related disorders. Asceneuron is a privately held company financed by a renowned syndicate of investors consisting of Sofinnova Partners, M Ventures, SR One, Johnson & Johnson Innovation – JJDC, Inc. (JJDC) and Kurma Partners. For more information, please visit www.asceneuron.com. Further information: www.asceneuron.com

Headquarters

Ch

Website

asceneuron.com

Industry

Biotechnology Research

Founded

2012

NAICS

Research and Development in Biotechnology (except Nanobiotechnology)

Company Email

Available in AeroLeads

Asceneuron SA Contact Intelligence

See which contact channels and departments are represented in the visible AeroLeads data.

Asceneuron SA People & Org Chart Preview

Sample people records show job titles and whether email or phone data is available without exposing raw contact details.

Asceneuron SA Workforce Composition

Seniority breakdown across 8 visible profiles.

Asceneuron SA Technology & Talent

Technology-related job titles represented in the visible people data.

Compare Similar Companies to Asceneuron SA

Explore companies in related markets and compare their industry and employee estimates.